Keyphrases
Hepatitis B Virus
100%
Hepatitis B Surface Antigen (HBsAg)
55%
COVID-19
46%
T Cells
44%
Recombinant
37%
Gene Delivery
33%
Hydrodynamic Injection
33%
Point-of-care
33%
Chimeric Antigen Receptor T Cells (CAR-T)
32%
Red Blood Cells
26%
Liver
25%
Hemagglutination
21%
Therapeutic Strategies
21%
Covalently Closed Circular DNA
20%
Adoptive Immunotherapy
20%
Antiviral Activity
20%
Solid Tumors
20%
Cell Agglutination
20%
Infected Patients
20%
Viremia
20%
Receptor-binding Domain
20%
Drug Repurposing
20%
Agglutination Assay
20%
Pig Liver
19%
Plasmid
18%
Episomal
18%
Human Liver chimeric Mice
16%
Viral Immunotherapy
16%
CD3 Bispecific
16%
Co-infection
16%
Engineered Cytokines
16%
Hepatitis C Virus
16%
Clinical Outcomes
16%
Tumor Elimination
16%
Isohemagglutinins
16%
Rhodococcus Equi
16%
United States
16%
Titering
16%
Clinically Significant
16%
Endoscopic Retrograde Cholangiopancreatography
16%
Constitutive Signaling
16%
IL-7 Receptor
16%
Hemagglutinin
16%
Antibody Level
16%
Asthma
16%
Antigenemia
16%
Bispecific Antibody
16%
Allergy
16%
Cryoprecipitate
16%
Cytokine Signaling
16%
Immunology and Microbiology
Hepatitis B Virus
83%
T Cell
41%
Immunotherapy
34%
HBsAg
34%
Hepatitis B Antigen
34%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Blood Plasma
28%
Immunology
24%
Hemagglutination
19%
Viremia
18%
Plasmid
18%
Antiviral Activity
17%
COVID-19
17%
Coronavirinae
16%
Hepatitis C Virus
16%
Coinfection
16%
Antisense
16%
Bispecific Antibody
16%
LoxP Site
16%
Titer
16%
Hemagglutinin
16%
Genetic Transfection
16%
Cryoprecipitate
16%
Cytokine Signaling
16%
Solid
16%
CD3 Antigen
16%
Chimeric Antigen Receptor T-Cell
13%
Antigen-Antibody Interaction
12%
Membrane Antigen
11%
Antibody Titer
10%
Neutralizing Antibody
10%
Chimeric Antigen Receptor
10%
DNA Virus
9%
Hepatitis B
8%
Dilution
7%
Enzyme-Linked Immunosorbent Assay
6%
Lateral Flow Assay
6%
Engineered Cell
6%
Transfusion Medicine
5%
Coenzyme
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Gene Targeting
33%
Hepatitis B Virus
33%
Erythrocyte
25%
COVID-19
24%
Endoscopic Retrograde Cholangiopancreatography
23%
Cell Agglutination
20%
Red Cell Agglutination
20%
Receptor Binding
20%
Xenograft
19%
Viremia
18%
Antisense Oligonucleotide
16%
Plasmid DNA
16%
Hepatitis C Virus
16%
Neoplasm
16%
Plasma Exchange
16%
Receptor
16%
Familial Hypercholesterolemia
16%
Myopathy
16%
Gene Therapy
16%
T Cell
16%
Mixed Infection
16%
Angiotensin Converting Enzyme 2
16%
Coronavirinae
16%
Antigen Antibody Reaction
14%
Infection
13%
Factor IX
13%
Neutralizing Antibody
11%
Lateral Flow Assay
10%
Enzyme Linked Immunosorbent Assay
10%
Hemagglutination Test
10%
Immunoassay
10%
Hepatocyte
10%
Vital Sign
10%
Liver Disease
10%
Membrane Antigen
7%
Virus DNA
7%
Liver Enzyme
6%
LDL Receptor
6%
Adeno-Associated Virus
6%
Hepatobiliary System
6%
Clinical Trial
6%
Genetic Transfection
6%
Liver Cirrhosis
6%
Hepatocellular Carcinoma
6%
Chimeric Protein
6%
Hydrodynamics Based Transfection
5%
Creatine Kinase
5%
Oxidoreductase
5%
HMG-CoA
5%
